Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adoptive immunotherapy for cancer.

× No keyword cloud information.

9 in total

Review 1. Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling.

Authors: Helen Y Wang; Rong-Fu Wang
Journal: Adv Immunol Date: 2012 Impact factor: 3.543

Review 2. Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.

Authors: Hui-Chuan Sun; Zhao-You Tang
Journal: World J Gastroenterol Date: 2003-04 Impact factor: 5.742

3. Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: comparison with physiologically based pharmacokinetic model.

Authors: Robert J Melder; Lance L Munn; Brian R Stoll; Edgardo M Marecos; Laurence T Baxter; Ralph Weissleder; Rakesh K Jain
Journal: Neoplasia Date: 2002 Jan-Feb Impact factor: 5.715

Review 4. Immune targets and neoantigens for cancer immunotherapy and precision medicine.

Authors: Rong-Fu Wang; Helen Y Wang
Journal: Cell Res Date: 2016-12-27 Impact factor: 25.617

5. Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma.

Authors: A S Chong; E D Staren; P Scuderi
Journal: Cancer Immunol Immunother Date: 1992 Impact factor: 6.968

6. Kinetics of interleukin-2 induced changes in rigidity of human natural killer cells.

Authors: R J Melder; R K Jain
Journal: Cell Biophys Date: 1992 Apr-Jun

7. Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activity.

Authors: L T Balemans; V Mattijssen; P A Steerenberg; B E Van Driel; P H De Mulder; W Den Otter
Journal: Cancer Immunol Immunother Date: 1993-07 Impact factor: 6.968

8. Antibody-directed effector cell therapy of tumors: analysis and optimization using a physiologically based pharmacokinetic model.

Authors: Stuart W Friedrich; Stephany C Lin; Brian R Stoll; Laurence T Baxter; Lance L Munn; Rakesh K Jain
Journal: Neoplasia Date: 2002 Sep-Oct Impact factor: 5.715

9. Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.

Authors: J Kan-Mitchell; P E Liggett; W Harel; L Steinman; T Nitta; J R Oksenberg; M R Posner; M S Mitchell
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968

9 in total